Table 1. Summary of patient and urine specimen classifications used in this study.
| Description | Classification | Number of samples | Source of data |
|---|---|---|---|
| Patients with biopsy confirmed diabetic nephropathy (DKD) | DKD | 12 | This study |
| Patients with immune-mediated nephropathy (IMN) | IMN | 12 | This study |
| Patients with DM and no biopsy | DM+ | 161 | This study |
| Patients without DM and no biopsy | DM− | 65 | This study |
| DKD patients with IMN | DKD/IMN | 1 | This study |
| DKD patients with other varying pathologies | DKD/OT | 3 | This study |
| DKD patients with no other pathologies | DKD/NO | 9 | This study |
| IMN patients that are DM+ | IMN/DM+ | 6 | This study |
| IMN patients that are DM− | IMN/DM− | 6 | This study |
| Patients with membranous nephrology (cause unspecified) | MN | 6 | This study |
| Renal neoplasia | RN | 3 | This study |
| Other varying pathologies | OT | 4 | This study |
| Pathologies with no DM | PATH | 9 | This study |
| Healthy volunteers | HEALTHY | 25 | Huttanus et al. (2020) |
| Surine™ urinalysis control | SURINE | 22 | This study |